These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 9600207)

  • 1. Caprine mucopolysaccharidosis-IIID: clinical, biochemical, morphological and immunohistochemical characteristics.
    Jones MZ; Alroy J; Boyer PJ; Cavanagh KT; Johnson K; Gage D; Vorro J; Render JA; Common RS; Leedle RA; Lowrie C; Sharp P; Liour SS; Levene B; Hoard H; Lucas R; Hopwood JJ
    J Neuropathol Exp Neurol; 1998 Feb; 57(2):148-57. PubMed ID: 9600207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caprine mucopolysaccharidosis IIID: fetal and neonatal brain and liver glycosaminoglycan and morphological perturbations.
    Jones MZ; Alroy J; Downs-Kelly E; Lucas RE; Kraemer SA; Cavanagh KT; King B; Hopwood JJ
    J Mol Neurosci; 2004; 24(2):277-91. PubMed ID: 15456941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caprine mucopolysaccharidosis IIID: a preliminary trial of enzyme replacement therapy.
    Downs-Kelly E; Jones MZ; Alroy J; Cavanagh KT; King B; Lucas RE; Baker JC; Kraemer SA; Hopwood JJ
    J Mol Neurosci; 2000 Dec; 15(3):251-62. PubMed ID: 11303788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human mucopolysaccharidosis IIID: clinical, biochemical, morphological and immunohistochemical characteristics.
    Jones MZ; Alroy J; Rutledge JC; Taylor JW; Alvord EC; Toone J; Applegarth D; Hopwood JJ; Skutelsky E; Ianelli C; Thorley-Lawson D; Mitchell-Herpolsheimer C; Arias A; Sharp P; Evans W; Sillence D; Cavanagh KT
    J Neuropathol Exp Neurol; 1997 Oct; 56(10):1158-67. PubMed ID: 9329460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic studies of glycosphingolipid accumulation in mucopolysaccharidosis IIID.
    Liour SS; Jones MZ; Suzuki M; Bieberich E; Yu RK
    Mol Genet Metab; 2001 Mar; 72(3):239-47. PubMed ID: 11243730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme Replacement Therapy for Mucopolysaccharidosis IIID using Recombinant Human α-
    Wang F; Moen DR; Sauni C; Kan SH; Li S; Le SQ; Lomenick B; Zhang X; Ekins S; Singamsetty S; Wood J; Dickson PI; Chou TF
    Mol Pharm; 2021 Jan; 18(1):214-227. PubMed ID: 33320673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic basis of mucopolysaccharidosis type IIID (MIM 252940) revealed by sequencing of GNS encoding N-acetylglucosamine-6-sulfatase.
    Mok A; Cao H; Hegele RA
    Genomics; 2003 Jan; 81(1):1-5. PubMed ID: 12573255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfamidase deficiency in a family of Dachshunds: a canine model of mucopolysaccharidosis IIIA (Sanfilippo A).
    Fischer A; Carmichael KP; Munnell JF; Jhabvala P; Thompson JN; Matalon R; Jezyk PF; Wang P; Giger U
    Pediatr Res; 1998 Jul; 44(1):74-82. PubMed ID: 9667374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosaminoglycans and mucopolysaccharidosis type III.
    Jakobkiewicz-Banecka J; Gabig-Ciminska M; Kloska A; Malinowska M; Piotrowska E; Banecka-Majkutewicz Z; Banecki B; Wegrzyn A; Wegrzyn G
    Front Biosci (Landmark Ed); 2016 Jun; 21(7):1393-409. PubMed ID: 27100513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sanfilippo syndrome type D: natural history and identification of 3 novel mutations in the GNS Gene.
    Jansen AC; Cao H; Kaplan P; Silver K; Leonard G; De Meirleir L; Lissens W; Liebaers I; Veilleux M; Andermann F; Hegele RA; Andermann E
    Arch Neurol; 2007 Nov; 64(11):1629-34. PubMed ID: 17998446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ultrastructure of skin from a patient with mucopolysaccharidosis IIID.
    Alroy J; Jones MZ; Rutledge JC; Taylor JW; Toone J; Applegarth D; Hopwood JJ
    Acta Neuropathol; 1997 Feb; 93(2):210-3. PubMed ID: 9039471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of intracellular amyloid-beta peptide (A beta 1-40) in mucopolysaccharidosis brains.
    Ginsberg SD; Galvin JE; Lee VM; Rorke LB; Dickson DW; Wolfe JH; Jones MZ; Trojanowski JQ
    J Neuropathol Exp Neurol; 1999 Aug; 58(8):815-24. PubMed ID: 10446806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of brain pathology in heparan sulphate storing mucopolysaccharidoses.
    Derrick-Roberts A; Kaidonis X; Jackson MR; Liaw WC; Ding X; Ong C; Ranieri E; Sharp P; Fletcher J; Byers S
    Mol Genet Metab; 2020; 131(1-2):197-205. PubMed ID: 32739280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomal storage of heparan sulfate causes mitochondrial defects, altered autophagy, and neuronal death in the mouse model of mucopolysaccharidosis III type C.
    Pshezhetsky AV
    Autophagy; 2016 Jun; 12(6):1059-60. PubMed ID: 25998837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome).
    Bhaumik M; Muller VJ; Rozaklis T; Johnson L; Dobrenis K; Bhattacharyya R; Wurzelmann S; Finamore P; Hopwood JJ; Walkley SU; Stanley P
    Glycobiology; 1999 Dec; 9(12):1389-96. PubMed ID: 10561464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Child Neurology: Mucopolysaccharidosis IIID: Evidence From Ultrastructural and Genomic Study.
    Santhoshkumar R; Mahale RR; Kishore PK; Chickabasaviah YT
    Neurology; 2023 Oct; 101(15):e1572-e1576. PubMed ID: 37487748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional correction of CNS lesions in an MPS-IIIA mouse model by intracerebral AAV-mediated delivery of sulfamidase and SUMF1 genes.
    Fraldi A; Hemsley K; Crawley A; Lombardi A; Lau A; Sutherland L; Auricchio A; Ballabio A; Hopwood JJ
    Hum Mol Genet; 2007 Nov; 16(22):2693-702. PubMed ID: 17725987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model of mucopolysaccharidosis IIIB (Sanfilippo syndrome type IIIB): N-acetyl-alpha-D-glucosaminidase deficiency in Schipperke dogs.
    Ellinwood NM; Wang P; Skeen T; Sharp NJ; Cesta M; Decker S; Edwards NJ; Bublot I; Thompson JN; Bush W; Hardam E; Haskins ME; Giger U
    J Inherit Metab Dis; 2003; 26(5):489-504. PubMed ID: 14518829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive binding of extracellular accumulated heparan sulfate reduces lysosomal storage defects and triggers neuronal differentiation in a model of Mucopolysaccharidosis IIIB.
    De Pasquale V; Scerra G; Scarcella M; D'Agostino M; Pavone LM
    Biochim Biophys Acta Mol Cell Res; 2021 Oct; 1868(11):119113. PubMed ID: 34329663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential distribution of heparan sulfate glycoforms and elevated expression of heparan sulfate biosynthetic enzyme genes in the brain of mucopolysaccharidosis IIIB mice.
    McCarty DM; DiRosario J; Gulaid K; Killedar S; Oosterhof A; van Kuppevelt TH; Martin PT; Fu H
    Metab Brain Dis; 2011 Mar; 26(1):9-19. PubMed ID: 21225451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.